These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9544945)

  • 1. Biosynthetic studies on the alpha-glucosidase inhibitor acarbose in Actinoplanes sp.: glutamate is the primary source of the nitrogen in acarbose.
    Lee S; Egelkrout E
    J Antibiot (Tokyo); 1998 Feb; 51(2):225-7. PubMed ID: 9544945
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of acarbose phosphate by a cell-free extract from the acarbose producer Actinoplanes sp.
    Goeke K; Drepper A; Pape H
    J Antibiot (Tokyo); 1996 Jul; 49(7):661-3. PubMed ID: 8784426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthetic studies on the alpha-glucosidase inhibitor acarbose in Actinoplanes sp.: source of the maltose unit.
    Lee S; Sauerbrei B; Niggemann J; Egelkrout E
    J Antibiot (Tokyo); 1997 Nov; 50(11):954-60. PubMed ID: 9592570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acarbose is a competitive inhibitor of mammalian lysosomal acid alpha-D-glucosidases.
    Calder PC; Geddes R
    Carbohydr Res; 1989 Aug; 191(1):71-8. PubMed ID: 2776140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AcbC protein from Actinoplanes species is a C7-cyclitol synthase related to 3-dehydroquinate synthases and is involved in the biosynthesis of the alpha-glucosidase inhibitor acarbose.
    Stratmann A; Mahmud T; Lee S; Distler J; Floss HG; Piepersberg W
    J Biol Chem; 1999 Apr; 274(16):10889-96. PubMed ID: 10196166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutrient digestibility and N-balance after administration of an alpha-glucosidase inhibitor to pigs].
    Roth FX; Kirchgessner M
    Z Tierphysiol Tierernahr Futtermittelkd; 1980; 44(2):57-63. PubMed ID: 6252715
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of alpha-glucosidase inhibitor on burning epigastralgia in dumping syndrome: a case report].
    Mimura M; Tsukakubo T; Tsujiguchi N; Hoshikawa T
    Masui; 1996 Mar; 45(3):337-9. PubMed ID: 8721135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose.
    Wehmeier UF; Piepersberg W
    Appl Microbiol Biotechnol; 2004 Feb; 63(6):613-25. PubMed ID: 14669056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the biosynthesis of the alpha-glucosidase inhibitor acarbose: valienamine, a m-C7N unit not derived from the shikimate pathway.
    Degwert U; van Hülst R; Pape H; Herrold RE; Beale JM; Keller PJ; Lee JP; Floss HG
    J Antibiot (Tokyo); 1987 Jun; 40(6):855-61. PubMed ID: 3301773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal glycogen storage induced by Acarbose, a 1,4-alpha-glucosidase inhibitor.
    Geddes R; Taylor JA
    Biochem J; 1985 Jun; 228(2):319-24. PubMed ID: 3893420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
    Schwartzkopff W; Calder D
    Med Welt; 1984 Feb; 35(6):169-74. PubMed ID: 6369065
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP; Tierney AR; Kral JG; Bjorntorp P
    Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
    Hayakawa T; Noda A; Kondo T; Okumura N
    Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus.
    Dimitriadis G; Karaiskos C; Raptis S
    Horm Metab Res; 1986 Apr; 18(4):253-5. PubMed ID: 3519413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of alpha-glucosidase-inhibitors.
    Fölsch UR
    Hepatogastroenterology; 1982 Apr; 29(2):47-8. PubMed ID: 7044933
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alpha-amylase and glucosidase inhibitors].
    Maranesi M
    Clin Ter; 1986 Apr; 117(1):23-30. PubMed ID: 3522064
    [No Abstract]   [Full Text] [Related]  

  • 17. Acarbose for diabetes mellitus.
    Med Lett Drugs Ther; 1996 Feb; 38(967):9-10. PubMed ID: 8559114
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of disaccharide digestion in rat intestine by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Puls W
    Digestion; 1982; 23(4):232-8. PubMed ID: 6754513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Streptococcus mutans glucosyltransferase inhibition by alpha-glucosidase inhibitors].
    Felgenhauer B; Trautner K
    Dtsch Zahnarztl Z; 1981; 36(12):841-4. PubMed ID: 6459227
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nutritive effects of an intestinal alpha-glucosidases-inhibition in rats (author's transl)].
    Kirchgessner M; Roth FX; Spoerl R
    Res Exp Med (Berl); 1981; 178(3):211-7. PubMed ID: 7015437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.